News for Healthier Living

Semaglutide More Effective at Lowering Risk for Stroke and Other Cardiovascular Outcomes Compared to Empagliflozin

Two target trial emulation studies compared mortality and cardiovascular risks in adult patients treated with semaglutide or dulaglutide versus empagliflozin.

June 16, 2025


June 16 2025

June 15 2025

June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025

June 9 2025

June 8 2025

June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025